In contrast to ABT-737 platelet apoptosis drug inducer, the treatment with ITP plasma, TNF, FasL or TWEAK showed no effects in the activation of caspase-8 and-3, suggesting a selective caspase-8 induction. This evidence concerns the gene FASLG and autoimmune thrombocytopenic purpura.